Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Crack cocaine : a practical treatment approach for the chemically dependent / / Barbara C. Wallace
| Crack cocaine : a practical treatment approach for the chemically dependent / / Barbara C. Wallace |
| Autore | Wallace Barbara C. |
| Pubbl/distr/stampa | New York : , : Routledge, , 2012 |
| Descrizione fisica | 1 online resource (576 p.) |
| Disciplina |
616.864706
616.8647 |
| Collana |
Fast facts
Questions and answers |
| Soggetto topico |
Crack (Drug)
Cocaine abuse - Treatment |
| ISBN |
1-138-00481-2
1-315-80369-0 1-317-77230-X 1-317-77231-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Half Title; Title Page; Copyright Page; Dedication; Table of Contents; Preface; Acknowledgments; Introduction; I. Crack: The Nature of the Treatment Challenge; 1. Societal Demand, the Art of Drug Distribution, and the Pharmacology of Crack; Societal Demand for Chemicals; Intranasal Cocaine Usage: America's Favorite New Drug; A New Sociocultural Ritual: Cocaine Free-Base Smoking; Crack: A Packaging and Marketing Breakthrough; Pre-Packaging for the Most Efficient Route of Administration; State-of-the-Art Drug-Dealing Methodology; Crack: America's Biggest Drug Problem
The Pharmacology of CocaineAnimal Studies: Cocaine's Reinforcing Properties; Cocaine's Impact on the Brain Reward Center; The Neurochemical Actions of Cocaine; Cocaine Reconceptualized: A Uniquely Addicting Drug; Crack: The Most Addictive Form of Cocaine; Conclusion; 2. DSM-III-R: Diagnosing Cocaine Dependence and Other Psychopathology; Cocaine Use and the DSM-III-R; Recreational Use of Illicit Chemicals; Psychoactive Substance Abuse and Dependence; Crack-Cocaine Dependence; Crack-Cocaine Abuse; Sequence of Stages in Chemical Use; "You Dare Smoke Crack": Providing Preventative Education Affective and Personality Disorders in the Crack DependentPsychopathology: Disagreement, Confusion, and Scant Data; Research Studies with Cocaine Users in Treatment; Summary Interpretation of Research; Deficits in Self-Regulatory Capacities; Beyond DSM-III-R: The Predominance of Narcissism; Conclusion; 3. Psychosocial Characteristics of the Crack Dependent; Dysfunctional Family Histories in Childhood; Crack-Related Deterioration: Adding Insult to Injury; Crack-Related Changes in Employment Patterns; Patterns of Crack-Cocaine Smoking; A Predominance of Daily Smokers Binge Use Constituting DependenceExternal Controls Affect Crack-Smoking Patterns; Competing Rewards Set Limits on Crack Use; Escalation to Frequent Crack Use; Diversity in Self-Administered Doses; Overall Evidence of Severe Dependence; Other Drug-Use Patterns; Consequences of Crack-Smoking Patterns; Patterns of Homelessness Attributable to Crack Addiction; Crack Smokers' Inability to Care for Children; Crack-Related Familial Discord; Criminal Involvement; High Levels of Sexual Activity; Crack Use: A Well-Kept Secret; Conclusion; II. Theory and Implications for Clinical Technique 4. Pharmacological ApproachesWhy Use Pharmacological Adjuncts?; Pharmacological Adjuncts as Relapse Prevention; Use in Specific Phases of Recovery; Individual Classes of Agents vs A More Complete Approach; Psychotropic Medication for Psychiatric Illness; An Integrated Perspective and Rationale for the Use of Pharmacological Adjuncts; Implications of Theory for Treatment; Limitations of Pharmacological Adjuncts as a Treatment Tool; Conclusion; 5. Psychoanalytic Approaches; Adult Children of Alcoholic and Dysfunctional Families; A Consequence of ACA Status: A Susceptibility to Alcoholism Growing Recognition of a Risk for Chemical Dependency |
| Record Nr. | UNINA-9910702907603321 |
Wallace Barbara C.
|
||
| New York : , : Routledge, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Development of medications for the treatment of opiate and cocaine addictions [[electronic resource] ] : issues for the government and private sector / / Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
| Development of medications for the treatment of opiate and cocaine addictions [[electronic resource] ] : issues for the government and private sector / / Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| Pubbl/distr/stampa | Washington, DC, : National Academy Press, 1995 |
| Descrizione fisica | xvii, 250 p. : ill |
| Disciplina | 616.86/32061 |
| Altri autori (Persone) |
FulcoCarolyn
LivermanCatharyn T EarleyLaurence E |
| Soggetto topico |
Drug addiction - Treatment
Cocaine abuse - Treatment Substance abuse - Treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-19299-2
9786610192991 0-309-58791-3 0-585-02541-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456005403321 |
| Washington, DC, : National Academy Press, 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Development of medications for the treatment of opiate and cocaine addictions [[electronic resource] ] : issues for the government and private sector / / Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
| Development of medications for the treatment of opiate and cocaine addictions [[electronic resource] ] : issues for the government and private sector / / Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| Pubbl/distr/stampa | Washington, DC, : National Academy Press, 1995 |
| Descrizione fisica | xvii, 250 p. : ill |
| Disciplina | 616.86/32061 |
| Altri autori (Persone) |
FulcoCarolyn
LivermanCatharyn T EarleyLaurence E |
| Soggetto topico |
Drug addiction - Treatment
Cocaine abuse - Treatment Substance abuse - Treatment |
| ISBN |
0-309-17652-2
1-280-19299-2 9786610192991 0-309-58791-3 0-585-02541-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778654103321 |
| Washington, DC, : National Academy Press, 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Development of medications for the treatment of opiate and cocaine addictions : issues for the government and private sector / / Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
| Development of medications for the treatment of opiate and cocaine addictions : issues for the government and private sector / / Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, DC, : National Academy Press, 1995 |
| Descrizione fisica | xvii, 250 p. : ill |
| Disciplina | 616.86/32061 |
| Altri autori (Persone) |
FulcoCarolyn
LivermanCatharyn T EarleyLaurence E |
| Soggetto topico |
Drug addiction - Treatment
Cocaine abuse - Treatment Substance abuse - Treatment |
| ISBN |
0-309-17652-2
1-280-19299-2 9786610192991 0-309-58791-3 0-585-02541-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector -- Copyright -- Acknowledgments -- Preface -- Note to the Reader -- Contents -- Executive Summary -- STATE OF THE SCIENTIFIC KNOWLEDGE ON ADDICTION -- NIDA'S MEDICATIONS DEVELOPMENT DIVISION -- EFFECTIVENESS OF TREATMENT -- TREATMENT FINANCING -- TRAINING AND EDUCATION -- FEDERAL REGULATORY ISSUES -- Food and Drug Administration -- Drug Enforcement Administration -- STATE REGULATORY ISSUES -- Interim Actions -- Long-Term Actions -- MARKET OBSTACLES AND CREATING INCENTIVES -- Size of the Market -- Drug Pricing and Intellectual Property Rights -- Societal Stigma -- NEED FOR FEDERAL LEADERSHIP -- CONCLUSIONS -- OPTIONS FOR FURTHER CONSIDERATION -- REFERENCES -- 1 Introduction -- PUBLIC-HEALTH REPERCUSSIONS OF ILLICIT DRUG USE -- Health Consequences: Violence -- Health Consequences: AIDS -- Health Consequences: Tuberculosis -- Health Consequences: Drug-exposed Infants -- ECONOMIC COSTS OF ILLICIT DRUG USE TO SOCIETY -- EXTENT OF ILLICIT DRUG USE -- ROLE OF PHARMACOTHERAPY -- REFERENCES -- 2 Overview of the State of Scientific Knowledge Concerning Drug Addiction -- CONCEPTS OF DRUG ADDICTION -- BIOLOGICAL CORRELATES AND PSYCHOPHARMACOLOGY OF ADDICTION -- Opiate Addiction -- Cocaine Addiction -- MDD AND STRATEGIES FOR THE DISCOVERY OF A COCAINE MEDICATION: DESCRIPTION AND CRITICAL ANALYSIS -- Introduction -- Source of Compounds -- Medication Preclinical Screening -- In Vitro Screen-Receptors and Mechanisms of Action -- In Vivo Screen-Behavioral Tests -- Specific Conclusions and Recommendations for the MDD -- Clinical Trials -- Human Behavioral Models -- CONCLUSIONS AND RECOMMENDATIONS -- REFERENCES -- 3 Assessment of the Medications Development Division -- STRUCTURE AND FUNCTIONS OF THE MEDICATIONS DEVELOPMENT DIVISION.
Mission and History -- Research Focus on Opiates and Cocaine -- Program Objectives -- Organizational Structure -- Budget Process -- Resources and Funding Instruments -- Types of Grants and Contracts -- Interagency Agreements -- CRADAs -- Screening Agreements -- Training -- RELATIONSHIPS WITH OTHER FEDERAL AGENCIES AND THE PRIVATE SECTOR -- Food and Drug Administration -- Drug Enforcement Administration -- Office of Protection from Research Risks -- Pharmaceutical Industry -- ASSESSMENT OF THE MEDICATIONS DEVELOPMENT DIVISION -- Staff and Resources -- Drug-Discovery Programs -- Clinical Trials -- Clinical-Research Training -- Relationships with Regulatory Agencies -- Interaction with the Private Sector -- SUMMARY -- CONCLUSIONS AND RECOMMENDATIONS -- REFERENCES -- 4 Treatment Setting and Effectiveness -- TREATMENT SETTING -- Opiate Addiction -- Cocaine Addiction -- DEMOGRAPHIC AND FINANCIAL PROFILE -- Opiate-Dependent Patients -- Cocaine-Dependent Patients -- TREATMENT EFFECTIVENESS AND COST-EFFECTIVENESS -- Methadone Maintenance Treatment -- Effectiveness -- Cost-Effectiveness -- Cocaine Addiction Treatment -- Effectiveness -- Cost-Effectiveness -- CONCLUSIONS AND RECOMMENDATION -- REFERENCES -- 5 Treatment Financing and Trends in Health Insurance -- FINANCING OF TREATMENT -- Financing the Treatment of Opiate Addiction -- Financing the Treatment of Cocaine Addiction -- FINANCING OF LAAM FOR THE TREATMENT OF OPIATE ADDICTION -- IMPACT OF HEALTH INSURANCE TRENDS ON MEDICATIONS DEVELOPMENT -- Trends in Drug Abuse Treatment Benefits -- REFERENCES -- 6 Training and Education -- EXPANDING THE CORE OF RESEARCHERS AND CLINICIANS -- Training Programs -- Fellowships -- Certification -- Conclusions and Recommendations -- INCREASING KNOWLEDGE AND SKILLS AMONG PRIMARY CARE PHYSICIANS -- Required Education in Medical Schools -- Residency Training. Continuing Education -- Conclusions and Recommendations -- COMPREHENSIVE DRUG ABUSE CENTERS -- Proposed Model -- Existing Research and Training Centers -- CSAT Centers -- NIDA Research Centers -- Conclusions and Recommendations -- SUMMARY -- REFERENCES -- 7 Federal Laws and Regulations -- CREATION OF A DRUG BY THE PHARMACEUTICAL INDUSTRY -- FOOD AND DRUG ADMINISTRATION -- Recent Initiatives to Expedite Availability of New Drugs -- Market Exclusivity and Orphan Drug Status -- FDA Guidelines on Evaluation of Anti-Addiction Drugs -- DRUG ENFORCEMENT ADMINISTRATION -- Scheduling -- Quotas -- Regulatory Authority Over Anti-Addiction Drugs In Development -- CONCLUSIONS -- REFERENCES -- 8 State Laws and Regulations -- STATE REGULATORY LANDSCAPE -- Scheduling -- Treatment -- Admission Criteria -- Staffing Requirements -- Patient Registries -- Drug Screening -- Medication Take-Home Policies -- Clinical Research -- LAAM: A CASE STUDY -- Federal Regulations -- State Regulations -- Scheduling/Rescheduling -- Treatment Regulations -- Clinic Approval -- CONCLUSIONS -- RECOMMENDATIONS -- Interim Actions -- Long-Term Actions -- REFERENCES -- 9 Market Obstacles and Creating Incentives -- MARKET OBSTACLES TO PRIVATE-SECTOR INVESTMENT -- Nature and Size of the Market -- Drug Pricing and Intellectual Property Rights -- Societal Stigma -- Clinical Research on Anti-Addiction Medications -- Product Liability -- NEED FOR FEDERAL LEADERSHIP -- CONCLUSIONS -- OPTIONS FOR FURTHER CONSIDERATION -- REFERENCES -- Appendix A Acknowledgements -- Appendix B Organization and Mission Statements of NIDA's Medications Development Division and Its... -- MEDICATIONS DEVELOPMENT DIVISION MISSION STATEMENT -- Biometrics Branch Mission Statement -- Chemistry and Pharmaceutics Branch Mission Statement -- Clinical Trials Branch Mission Statement. Pharmacology and Toxicology Branch Mission Statement -- Regulatory Affairs Branch Mission Statement -- Appendix C Diagnostic Criteria for Psychoactive Substance Dependence -- Appendix D Survey of Pharmaceutical Companies -- ATTACHMENT 1 -- ATTACHMENT 2 -- Appendix E Model Federal Programs in Pharmaceutical R& -- D -- ANTIEPILEPTIC DRUG DEVELOPMENT PROGRAM -- Background -- Elements of Success -- NATIONAL CANCER INSTITUTE CANCER-DRUG DISCOVERY AND DEVELOPMENT PROGRAMS -- Background -- Preclinical Research -- Clinical Research -- Elements of Success -- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES DRUG DISCOVERY AND DEVELOPMENT PROGRAMS -- Background -- Preclinical Research -- Clinical Research -- Elements of Success -- REFERENCES -- Appendix F Workshop Agenda and Participants -- WORKSHOP AGENDA -- PARTICIPANT LIST -- Appendix G Health Care Reform Legislation -- UNIVERSALITY OF COVERAGE -- PRESCRIPTION DRUG BENEFITS -- DRUG ABUSE TREATMENT BENEFITS -- INSURANCE REFORM -- FINANCING HEALTH CARE REFORM AND THE FATE OF MEDICAID -- CONCLUSIONS -- REFERENCES -- Appendix H Acronyms. |
| Record Nr. | UNINA-9910828852203321 |
| Washington, DC, : National Academy Press, 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Les Flambeurs : Trajectoires d'usagers de cocaïne / / Serge Brochu et Isabelle Parent
| Les Flambeurs : Trajectoires d'usagers de cocaïne / / Serge Brochu et Isabelle Parent |
| Autore | Brochu Serge |
| Pubbl/distr/stampa | Ottawa : , : Presses de l'Universite d'Ottawa, , 2005 |
| Descrizione fisica | 1 online resource (244 p.) |
| Disciplina | 364.24 |
| Altri autori (Persone) | ParentIsabelle |
| Collana | Collection "Criminologie" |
| Soggetto topico |
Cocaine abuse - Treatment
Drug abuse - Patients - Attitudes Drug abuse and crime Cocaine abuse |
| Soggetto genere / forma | Electronic books. |
| ISBN | 2-7603-1647-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | fre |
| Nota di contenuto | Table des matières; Préface; Remerciements; Introduction; Chapitre 1 : La cocaïne; Chapitre 2 : La cocaïne et le crime; Chapitre 3 : L'étude; Chapitre 4 : L'initiation à un parcours d'usage de substances psychoactives illicites; Chapitre 5 : La consommation régulière de cocaïne; Chapitre 6 : La retraite : les efforts pour mettre fin à un itinéraire d'usage de drogues; Chapitre 7 : Les transformations de la relation drogue-crime au cours de la trajectoire de consommation; Synthèse et conclusion; Références |
| Record Nr. | UNINA-9910155853303321 |
|
Brochu Serge
|
||
| Ottawa : , : Presses de l'Universite d'Ottawa, , 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
